Similar findings were replicated in patients with T2DM (mean age 57.5 years, 49.2% female)
That's a different phenotype than someone who is consuming fast food all the time it doesn't have cravings for it, but just eats fast food
Dont let insurance challenges derail your progress affordable alternatives exist to keep you on track toward your health goals
Its trusted by medical professionals, athletes, and people on the go
Focus on victories such as improved energy levels, better sleep, or the ability to walk further
To date, these GLP-1 drugs have been approved to treat three adult populations: individuals with type 2 diabetes, individuals with a body mass index (BMI) of 30 or greater (obesity), and individuals with a BMI between 27 and 30 (overweight) with at least one weight-related health condition, such as cardiovascular disease, high blood pressure, high cholesterol, prior stroke, prior heart attack, and chest pain (angina)